SANDOZ PTY LTD, — Escitalopram Importer Profile
Pharmaceutical Importer · #15 buyer for Escitalopram · $1.9M import value · 51 shipments · AUSTRALIA · DGFT Verified
SANDOZ PTY LTD, is the #15 importer of Escitalopram from India with $1.9M in import value and 51 verified shipments. SANDOZ PTY LTD, holds a 0.9% market share in Escitalopram imports based in AUSTRALIA. The company sources from 1 verified supplier across 19 formulations shipped to 1 country.
SANDOZ PTY LTD, — Escitalopram Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Escitalopram to SANDOZ PTY LTD,?
Verified from 51 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $1.9M | 51 | 100.0% |
SANDOZ PTY LTD, sources Escitalopram from 1 verified Indian supplier based on 51 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does SANDOZ PTY LTD, Compare to Nearest Escitalopram Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 18 | ORION CORPORATION | FINLAND | $1.5M | 56 | $26.5K |
| 5 | AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $1.4M | 28 | $50.0K |
| 15 | SANDOZ PTY LTD, ★ | AUSTRALIA | $1.4M | 27 | $50.0K |
| 19 | APOTEX INC, | CANADA | $1.3M | 42 | $32.0K |
| 20 | MICRO LABS GMBH | GERMANY | $1.3M | 49 | $26.8K |
SANDOZ PTY LTD, ranks #15 among 628 Escitalopram importers from India. Average shipment value of $50.0K compared to the market average of $53.1K. The closest competitors by value are ORION CORPORATION and AUROLOGISTICS LLC AUROBINDO PHARM.
Where Does SANDOZ PTY LTD, Import Escitalopram To?
Destination countries from 51 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $1.9M | 51 | 100.0% |
SANDOZ PTY LTD, imports Escitalopram to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $1.9M.
What Escitalopram Formulations Does SANDOZ PTY LTD, Import?
| Formulation | Value | Shipments |
|---|---|---|
| ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG T | $950.0K | 19 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 10 MG T | $200.0K | 4 |
| ESCITALOPRAM SANDOZ (AS OXALATE)20 MG TA | $100.0K | 2 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG TABLET (ESCITALOPRAM). (INV.QTY.87460 PACK 2X14S=2448880 NOS)NOS | $63.6K | 3 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG TABLET (ESCITALOPRAM). (INV.QTY.87300 PACK 2X14S=2444400 NOS)NOS | $63.5K | 3 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG TABLET (ESCITALOPRAM). (INV.QTY.86960 PACK 2X14S=2434880 NOS) | $50.0K | 1 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG TABLET (ESCITALOPRAM). (INV.QTY.86880 PACK 2X14S=2432640 NOS) | $50.0K | 1 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG TABLET (ESCITALOPRAM). (INV. QTY. 86880 PACK 2X14S =2432640 NOS) | $50.0K | 1 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 10 MG TABLET (ESCITALOPRAM) . (INV.QTY.172800 PACK 2X14S=4838400 NOS) | $50.0K | 1 |
| ESCITALOPRAM SANDOZ (AS OXALATE) 10 MG TABLET (ESCITALOPRAM) . (INV.QTY.153120 PACK 2 X 14S =4287360 NOS ) | $50.0K | 1 |
SANDOZ PTY LTD, imports 19 distinct Escitalopram formulations from India. The top formulation is ESCITALOPRAM SANDOZ (AS OXALATE) 20 MG T with 19 shipments worth $950.0K.
Regulatory Requirements: Importing Escitalopram into Australia
What SANDOZ PTY LTD, and other importers must comply with to import Escitalopram from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Escitalopram
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Escitalopram from India and How Much Does SANDOZ PTY LTD, Import?
India exported $33.3M worth of Escitalopram through 5,457 shipments from 231 suppliers to 95 countries, serving 628 buyers globally. SANDOZ PTY LTD, imports $1.9M of this total, accounting for 0.9% of India's Escitalopram exports with 51 shipments from AUSTRALIA. This is verified from 51 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for SANDOZ PTY LTD,'s Escitalopram Imports?
SANDOZ PTY LTD,'s average Escitalopram order value is $36.5K per consignment, based on 51 shipments totaling $1.9M. SANDOZ PTY LTD, is based in AUSTRALIA and ranks #15 among all Escitalopram importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Escitalopram to SANDOZ PTY LTD,?
SANDOZ PTY LTD, sources Escitalopram from 1 verified Indian supplier: CIPLA LIMITED ($1.9M, 100.0%). This is based on 51 customs records.
How Does SANDOZ PTY LTD, Compare to Other Escitalopram Importers?
SANDOZ PTY LTD, ranks #15 among 628 Escitalopram importers from India with a 0.9% market share. The top 3 importers are TORRENT PHARMA INC ($4.2M), LEK S.A. ($4.1M), CIPLA MAROC ($3.5M). SANDOZ PTY LTD, processed 51 shipments from AUSTRALIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Escitalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Escitalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SANDOZ PTY LTD, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SANDOZ PTY LTD,'s capped import value divided by total capped export value for Escitalopram across all Indian exporters.
- 5.Verified Records: This page is backed by 51 individual customs records matching SANDOZ PTY LTD, importing Escitalopram, covering 19 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 95+ countries, 628+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Escitalopram Import Data for SANDOZ PTY LTD,
Access order-level details, pricing data, supplier connections, and competitive analysis for SANDOZ PTY LTD,'s Escitalopram imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SANDOZ PTY LTD,
Company Profile
Multiple products · $0 total trade · Multiple categories
SANDOZ PTY LTD, × Escitalopram
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SANDOZ PTY LTD,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Escitalopram. For current order-level data, contact TransData Nexus.